Light Horse Therapeutics
San Diego
About Light Horse Therapeutics
Light Horse Therapeutics is the gene editing applied to small-molecule drug discovery, pioneering approaches to target the root causes of disabling and life-threatening diseases. Its advanced platform identifies cryptic chemically accessible functional domains within targets that are critical in disease biology. Our initial focus addresses high-value, historically challenging oncology targets with the opportunity to apply the technology to other therapeutic areas in the future.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $62.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2025)
- Website: lighthorsetx.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/light-horse-therapeutics-98115 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.